- Must have a screening CA-125 of greater than or equal to 40 U/ml.
- Must have received only one prior platinum/taxane-based chemotherapy regimen.
- Females who are pregnant or nursing.
- Any unstable, pre-existing major medical condition or history of other cancers.
within 28 days prior to entering the study.